ABN AMRO Investment Solutions’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.3M | Sell |
47,798
-532
| -1% | -$59K | 0.11% | 151 |
|
|
2025
Q1 | $5.42M | Buy |
48,330
+13,266
| +38% | +$1.49M | 0.11% | 154 |
|
|
2024
Q4 | $3.24M | Buy |
35,064
+390
| +1% | +$36K | 0.06% | 205 |
|
|
2024
Q3 | $2.91M | Sell |
34,674
-574
| -2% | -$48.1K | 0.05% | 221 |
|
|
2024
Q2 | $2.42M | Sell |
35,248
-302
| -0.8% | -$20.7K | 0.04% | 233 |
|
|
2024
Q1 | $2.6M | Sell |
35,550
-907,191
| -96% | -$66.5M | 0.05% | 234 |
|
|
2023
Q4 | $76.4M | Buy |
942,741
+14,006
| +2% | +$1.13M | 1.34% | 21 |
|
|
2023
Q3 | $69.6M | Sell |
928,735
-2,192
| -0.2% | -$164K | 1.36% | 16 |
|
|
2023
Q2 | $71.7M | Buy |
930,927
+1,569
| +0.2% | +$121K | 1.44% | 15 |
|
|
2023
Q1 | $77.1M | Buy |
+929,358
| New | +$77.1M | 1.59% | 11 |
|